0,947  0,003  TNF expression inhibitor
0,937  0,001  Sulfotransferase substrate
0,937  0,003  CYP2C19 substrate
0,934  0,003  CYP2C9 substrate
0,920  0,002  UGT1A6 substrate
0,912  0,002  UGT1A9 substrate
0,914  0,004  CYP1A2 substrate
0,910  0,004  Teratogen
0,910  0,004  Embryotoxic
0,907  0,001  UGT1A4 substrate
0,908  0,003  UDP-glucuronosyltransferase substrate
0,896  0,001  UGT2B1 substrate
0,888  0,001  UGT2B15 substrate
0,879  0,004  Aldehyde oxidase inhibitor
0,874  0,003  Sensitization
0,875  0,004  Carcinogenic
0,874  0,004  Antihypercholesterolemic
0,871  0,004  Respiratory analeptic
0,872  0,006  CYP3A4 substrate
0,867  0,003  NOS3 expression inhibitor
0,866  0,003  NOS2 expression inhibitor
0,844  0,001  Androgen agonist
0,839  0,001  UGT2B4 substrate
0,834  0,002  Androgen antagonist
0,841  0,010  Antiinflammatory
0,824  0,002  Aromatase inhibitor
0,818  0,004  Cholesterol antagonist
0,814  0,005  Prostate cancer treatment
0,804  0,004  AR expression inhibitor
0,804  0,005  CYP2D6 substrate
0,805  0,009  Antineoplastic (breast cancer)
0,794  0,003  UGT1A1 substrate
0,800  0,013  Transcription factor NF kappa B inhibitor
0,788  0,003  Anesthetic general
0,790  0,005  Analeptic
0,784  0,003  Glutathione S-transferase substrate
0,784  0,005  Bone diseases treatment
0,768  0,005  Antiosteoporotic
0,776  0,014  Caspase 9 stimulant
0,774  0,020  Apoptosis agonist
0,752  0,001  UGT2B7 substrate
0,752  0,003  UGT1A3 substrate
0,749  0,001  SULT1A1 substrate
0,751  0,005  CTGF expression inhibitor
0,743  0,003  Hair growth stimulant
0,742  0,002  Postmenopausal disorders treatment
0,735  0,003  Endometrios treatment
0,731  0,003  Prostatic (benign) hyperplasia treatment
0,726  0,002  Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor
0,725  0,004  Hypoxia-inducible factor 1 alpha inhibitor
0,721  0,002  Contraceptive
0,721  0,008  Antineoplastic (ovarian cancer)
0,713  0,002  Estrogen receptor alpha antagonist
0,706  0,003  Antipruritic, allergic
0,698  0,002  Contraceptive male
0,697  0,006  Proliferative diseases treatment
0,692  0,003  NOS3 expression enhancer
0,688  0,004  Diuretic
0,685  0,000  UGT2B10 substrate
0,683  0,003  Estrogen agonist
0,681  0,001  Contraceptive female
0,675  0,011  Chemoprotective
0,661  0,001  Anabolic
0,662  0,003  Estrogen antagonist
0,664  0,008  Cardiovascular analeptic
0,658  0,004  Anesthetic
0,639  0,006  CYP2C19 inhibitor
0,623  0,001  UGT2B9 substrate
0,630  0,013  Radioprotector
0,615  0,002  Lipocortins synthesis antagonist
0,610  0,001  Aldosterone antagonist
0,598  0,002  Abortion inducer
0,603  0,011  Cytostatic
0,595  0,005  Genotoxic
0,584  0,002  Estradiol 17 beta-dehydrogenase inhibitor
0,593  0,014  Chemopreventive
0,579  0,004  Antiacne
0,583  0,015  Mutagenic
0,573  0,012  Apoptosis antagonist
0,574  0,013  Hepatic disorders treatment
0,575  0,016  Immunosuppressant
0,569  0,011  Antineoplastic (glioma)
0,568  0,015  Cytotoxic
0,554  0,003  Prostate disorders treatment
0,550  0,001  RNA-directed RNA polymerase stimulant
0,551  0,002  Progesterone antagonist
0,565  0,016  Antineoplastic (melanoma)
0,552  0,004  Psychosexual dysfunction treatment
0,541  0,004  Interferon gamma antagonist
0,536  0,003  Menstruation disorders treatment
0,539  0,009  Antineoplastic (glioblastoma multiforme)
0,539  0,013  Nitric oxide antagonist
0,524  0,002  Antipruritic, non-allergic
0,519  0,003  Antineoplastic, alkylator
0,519  0,002  Pregnane X receptor agonist
0,517  0,003  Estrogen receptor beta agonist
0,516  0,002  Estrogen receptor alpha agonist
0,514  0,000  UGT2B11 substrate
0,520  0,007  Carcinogenic, group 3
0,517  0,006  Interleukin 2 agonist
0,509  0,004  Sodium/bile acid cotransporter inhibitor
0,512  0,010  ICAM1 expression inhibitor
0,503  0,004  Estrogen receptor beta antagonist
0,536  0,039  Antineoplastic (lung cancer)
0,498  0,002  Estradiol 17 beta-dehydrogenase 3 inhibitor
0,496  0,005  Antialcoholic
0,502  0,014  Eye irritation, high
0,502  0,014  DNA damaging
0,507  0,021  Antineoplastic (pancreatic cancer)
0,487  0,004  Antiinfertility, female
0,486  0,010  Antineoplastic (liver cancer)
0,482  0,009  P-glycoprotein inhibitor
0,462  0,001  5-Alpha-reductase 1 inhibitor
0,459  0,000  Transcortin receptor antagonist
0,470  0,012  Antineoplastic (renal cancer)
0,451  0,006  Adenylate cyclase inhibitor
0,455  0,012  Interleukin agonist
0,445  0,003  LDLR expression enhancer
0,444  0,003  Cushing's syndrome treatment
0,438  0,001  5-Alpha-reductase 2 inhibitor
0,467  0,034  Antiallergic
0,450  0,019  Cardiodepressant
0,431  0,002  5-Alpha-reductase inhibitor
0,466  0,041  Antineoplastic (colorectal cancer)
0,459  0,039  Antineoplastic (colon cancer)
0,436  0,017  Antihypoxic
0,422  0,005  Antifungal enhancer
0,446  0,029  Antineoplastic (cervical cancer)
0,416  0,004  Cholesterol synthesis inhibitor
0,459  0,048  Antileukemic
0,422  0,012  Muscle relaxant
0,420  0,010  Melanin inhibitor
0,413  0,008  Muscular dystrophy treatment
0,433  0,029  Metabolic disease treatment
0,426  0,026  CYP3A4 inhibitor
0,432  0,035  Caspase 3 stimulant
0,427  0,030  Antioxidant
0,428  0,033  Antineoplastic (brain cancer)
0,395  0,003  Growth stimulant
0,395  0,003  Mineralocorticoid receptor antagonist
0,388  0,001  Postcoital contraceptive
0,429  0,042  Immunostimulant
0,396  0,014  Hepatoprotectant
0,388  0,011  Phospholipase C inhibitor
0,376  0,002  3(or 17)beta-hydroxysteroid dehydrogenase inhibitor
0,381  0,007  Toxic, respiratory center
0,376  0,004  Farnesoid X receptor antagonist
0,401  0,032  Antineoplastic (non-small cell lung cancer)
0,377  0,009  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,370  0,004  Alcohol dehydrogenase substrate
0,368  0,005  Autism spectrum disorders treatment
0,365  0,002  11-Beta-hydroxysteroid dehydrogenase 2 inhibitor
0,380  0,024  Antineoplastic (endocrine cancer)
0,381  0,030  Antineoplastic (lymphoma)
0,382  0,031  Antipyretic
0,357  0,007  Aldehyde dehydrogenase inhibitor
0,375  0,026  Angiogenesis stimulant
0,350  0,003  Bile acid receptor antagonist
0,359  0,012  Amylase inhibitor
0,352  0,009  Antipruritic
0,351  0,014  Skeletal muscle relaxant
0,367  0,034  Tumour necrosis factor alpha release inhibitor
0,340  0,008  Antihyperlipoproteinemic
0,348  0,019  Antiviral (Influenza)
0,329  0,001  Arachidonic acid antagonist
0,338  0,011  Neurotrophic factor enhancer
0,343  0,017  Male reproductive disfunction treatment
0,327  0,002  Hypogonadism treatment
0,326  0,002  Antihyperaldosteronism
0,324  0,002  Glucocorticoid antagonist
0,336  0,021  Skin irritative effect
0,341  0,026  GST M1-1 substrate
0,352  0,037  Antineoplastic (osteosarcoma)
0,344  0,031  DNA synthesis inhibitor
0,318  0,005  Anticataract
0,344  0,034  Antimitotic
0,343  0,040  FMO3 substrate
0,314  0,012  Alkylator
0,330  0,029  Antineoplastic (sarcoma)
0,304  0,005  VEGF expression inhibitor
0,356  0,058  Antifungal
0,303  0,006  Retinoprotector
0,325  0,028  Sedative
0,349  0,053  Lipoprotein disorders treatment
0,390  0,096  Cyclophilin D inhibitor
0,390  0,096  Antidiabetic
0,319  0,025  Antihypotensive
0,298  0,005  Beta tubulin antagonist
0,346  0,053  Calcium channel activator
0,297  0,005  Age-related macular degeneration treatment
0,345  0,053  Cardioprotectant
0,297  0,006  Phobic disorders treatment
0,297  0,006  Antieczematic
0,306  0,018  Lipid peroxidase inhibitor
0,290  0,002  Estradiol 17 beta-dehydrogenase 1 inhibitor
0,291  0,005  AMP-activated protein kinase stimulant
0,294  0,012  DNA polymerase I inhibitor
0,392  0,110  Antineoplastic (solid tumors)
0,319  0,038  Psychostimulant
0,309  0,031  Platelet adhesion inhibitor
0,282  0,006  Choleretic
0,291  0,017  Growth factor agonist
0,300  0,027  Antimutagenic
0,316  0,046  Antidiabetic symptomatic
0,286  0,018  Antiviral (Influenza A)
0,311  0,045  Vascular (periferal) disease treatment
0,267  0,005  Hedgehog signaling inhibitor
0,324  0,063  5 Hydroxytryptamine release stimulant
0,264  0,003  Glycine receptor agonist
0,262  0,002  Glycine receptor antagonist
0,261  0,004  Premenstrual syndrome treatment
0,303  0,048  Heart failure treatment
0,260  0,006  Microtubule formation inhibitor
0,257  0,005  Actinic keratosis treatment
0,256  0,005  Keratolytic
0,336  0,085  Stroke treatment
0,253  0,004  Adenylate cyclase stimulant
0,268  0,028  Antiviral (Herpes)
0,270  0,031  Diabetic retinopathy treatment
0,277  0,037  Growth hormone agonist
0,281  0,042  Antiparkinsonian, rigidity relieving
0,263  0,024  Tubulin antagonist
0,260  0,021  Interleukin 6 antagonist
0,243  0,005  Alpha tubulin antagonist
0,295  0,059  Transcription factor STAT inhibitor
0,294  0,059  Cardiotonic
0,258  0,023  Bone formation stimulant
0,228  0,001  SULT2A1 substrate
0,276  0,052  Gastrin inhibitor
0,278  0,057  Acute neurologic disorders treatment
0,226  0,008  Interleukin 8 antagonist
0,260  0,044  RNA-directed DNA polymerase inhibitor
0,216  0,004  Anticholelithogenic
0,287  0,074  Antineoplastic (multiple myeloma)
0,255  0,044  VCAM1 expression inhibitor
0,243  0,032  Antineoplastic (squamous cell carcinoma)
0,243  0,032  Antineoplastic (carcinoma)
0,325  0,117  Antibacterial
0,271  0,069  Flavin-containing monooxygenase substrate
0,202  0,002  Progesterone agonist
0,265  0,066  Antiprotozoal (Leishmania)
0,200  0,002  Na+ K+ transporting ATPase inhibitor
0,260  0,063  Hypolipemic
0,260  0,064  Free radical scavenger
0,214  0,025  Antirickettsial
0,245  0,057  Antineoplastic enhancer
0,226  0,040  Diabetic nephropathy treatment
0,288  0,103  Vasodilator, peripheral
0,192  0,010  Posttraumatic stress disorder treatment
0,188  0,008  SULT1E1 substrate
0,184  0,004  SULT1A2 substrate
0,201  0,021  Antihemorrhagic
0,203  0,033  Monophenol monooxygenase inhibitor
0,292  0,122  CYP2C9 inhibitor
0,177  0,008  Tocolytic
0,245  0,078  Myocardial infarction treatment
0,170  0,003  Estrogen-related receptor beta agonist
0,258  0,094  Antiepileptic
0,166  0,003  Estrone sulfatase inhibitor
0,202  0,041  Protein kinase stimulant
0,245  0,086  5 Hydroxytryptamine uptake stimulant
0,246  0,087  Transcription factor STAT3 inhibitor
0,228  0,070  Antiulcerative
0,216  0,060  Pneumotoxic
0,266  0,114  Antithrombotic
0,188  0,040  Skin whitener
0,144  0,002  Lipocortins synthesis agonist
0,269  0,128  GST A substrate
0,157  0,016  ABCA1 expression enhancer
0,194  0,053  Liver fibrosis treatment
0,180  0,040  SULT1A3 substrate
0,167  0,031  Liver cirrhosis treatment
0,167  0,031  Carcinogenic, group 2B
0,153  0,020  Neutropenia treatment
0,175  0,041  Neurotrophic factor
0,211  0,080  Antiparasitic
0,208  0,079  Antihypertriglyceridemic
0,174  0,050  Antidiarrheal
0,133  0,009  Narcotic antagonist
0,126  0,002  Pregnane X receptor antagonist
0,146  0,023  Toll-Like receptor 4 antagonist
0,124  0,002  Glucocorticoid agonist
0,125  0,005  Liver X receptor alpha agonist
0,153  0,036  Ca2+-transporting ATPase inhibitor
0,118  0,004  Andropause treatment
0,140  0,027  Prolactin inhibitor
0,144  0,032  Antineoplastic antibiotic
0,114  0,003  Adenylate cyclase 1 inhibitor
0,113  0,003  Glucose-6-phosphate dehydrogenase inhibitor
0,134  0,025  Acetylcholine nicotinic antagonist
0,152  0,047  Cyclooxygenase 3 inhibitor
0,126  0,022  Ornithine decarboxylase inhibitor
0,126  0,022  Inducible nitric-oxide synthase inhibitor
0,158  0,055  Antianemic
0,180  0,079  Antihelmintic
0,205  0,107  Hypoglycemic
0,116  0,020  CDC25A inhibitor
0,097  0,002  Corticosteroid-like
0,100  0,007  Heme oxygenase stimulant
0,230  0,138  Antihypertensive
0,126  0,035  Antineoplastic alkaloid
0,193  0,102  Antiglaucomic
0,117  0,027  Transcription factor NF kappa B stimulant
0,138  0,050  Coagulant
0,245  0,161  Antiobesity
0,093  0,009  Potassium channel Kv1.3 blocker
0,085  0,005  Farnesoid X receptor agonist
0,140  0,061  Alpha-N-acetylglucosaminidase inhibitor
0,086  0,008  Anesthetic inhalation
0,134  0,057  Anesthetic local
0,113  0,038  Lanosterol 14 alpha demethylase inhibitor
0,222  0,146  Angiogenesis inhibitor
0,206  0,133  Radiosensitizer
0,203  0,130  Renal disease treatment
0,155  0,082  Sigma receptor agonist
0,182  0,114  Antineoplastic (lymphocytic leukemia)
0,078  0,011  Liver X receptor agonist
0,071  0,006  Microtubule stabilization
0,147  0,082  Cyclin-dependent kinase 8 inhibitor
0,081  0,015  11-Beta-hydroxysteroid dehydrogenase 1 inhibitor
0,066  0,002  Hedgehog signaling activator
0,226  0,165  Inflammatory Bowel disease treatment
0,122  0,062  Protein-tyrosine phosphatase 1B inhibitor
0,081  0,022  Antimycoplasmal
0,097  0,038  Antiprotozoal activity enhancer
0,110  0,051  UDP-glucose 4-epimerase inhibitor
0,062  0,005  Cholesterol absorption inhibitor
0,084  0,031  Dysmenorrhea treatment
0,106  0,053  Creatine kinase inhibitor
0,118  0,066  Antitussive
0,097  0,047  Glutamate release inhibitor
0,205  0,158  Immunomodulator
0,098  0,055  Alcohol dehydrogenase inhibitor
0,096  0,054  Paget's disease treatment
0,215  0,174  FMO1 substrate
0,117  0,076  Cholinergic antagonist
0,047  0,006  Estrogen-related receptor beta antagonist
0,115  0,075  Acetylcholine antagonist
0,069  0,030  Alcohol oxidase inhibitor
0,071  0,032  Nitric oxide donor
0,040  0,002  Telomerase stimulant
0,103  0,065  Expectorant
0,089  0,052  Antispirochetal
0,216  0,179  Ulceration
0,074  0,037  Female sexual dysfunction treatment
0,105  0,071  Mucolytic
0,101  0,067  Beta glucuronidase inhibitor
0,106  0,073  Acetylcholine release stimulant
0,044  0,011  Tubulin agonist
0,062  0,030  GABA receptor antagonist
0,109  0,080  Antineoplastic antimetabolite
0,050  0,022  Parathyroid hormone antagonist
0,029  0,002  3 Beta-hydroxy-delta 5-steroid dehydrogenase inhibitor
0,031  0,005  Ileal bile acid transport inhibitor
0,028  0,003  Progesterone receptor A antagonist
0,134  0,109  CF transmembrane conductance regulator agonist
0,065  0,040  Calcium channel P-type blocker
0,042  0,018  2,3-Oxidosqualene-lanosterol cyclase inhibitor
0,039  0,016  Liver X receptor beta agonist
0,039  0,016  HMG CoA reductase inhibitor
0,040  0,017  Ceramide glucosyltransferase inhibitor
0,029  0,008  Vitamin D receptor antagonist
0,095  0,073  Antiviral (Poxvirus)
0,127  0,107  Acute respiratory distress syndrome (ARDS) treatment
0,065  0,047  Hypercalcemia treatment
0,053  0,037  GABA A receptor antagonist
0,022  0,006  Vitamin D receptor agonist
0,127  0,111  Neuropathy treatment
0,048  0,032  Adenosine deaminase inhibitor
0,175  0,160  Amyotrophic lateral sclerosis treatment
0,156  0,142  Cyclic AMP phosphodiesterase inhibitor
0,022  0,010  Progesterone receptor B antagonist
0,102  0,090  M18 aspartyl aminopeptidase inhibitor
0,122  0,111  Protein-tyrosine phosphatase inhibitor
0,064  0,054  Glutamate (mGluR6) antagonist
0,101  0,092  Antiviral (Hepatitis B)
0,032  0,023  Estrogen-related receptor alpha antagonist
0,100  0,091  Antiviral (SARS coronavirus)
0,100  0,091  Antiviral (Coronavirus)
0,031  0,024  ATP citrate lysase inhibitor
0,019  0,013  Apical sodium codependent bile acid transporter inhibitor
0,066  0,060  Antibiotic
0,053  0,048  Acetyl-CoA transferase 2 inhibitor
0,082  0,078  Breast cancer-resistant protein inhibitor
0,015  0,012  Thromboxane A2 agonist
0,132  0,129  Wound healing agent
0,021  0,018  GRP78 expression inhibitor
0,021  0,018  CYP24 inhibitor
0,073  0,071  Opioid kappa receptor antagonist
0,109  0,108  Antiprotozoal (Trichomonas)
0,052  0,051  Botulinum neurotoxin type A inhibitor
0,035  0,034  GABA uptake inhibitor
0,065  0,065  Phospholipase D inhibitor
0,020  0,020  Prostaglandin F2 alpha agonist

